Colombo, Valentina <br/><br/>
Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Feb 2011 
 - 369-79 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-010-1335-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols<br/>Apoptosis--drug effects<br/>Biological Transport--drug effects<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Colonic Neoplasms--drug therapy<br/>Doxorubicin--metabolism<br/>Drug Antagonism<br/>Drug Resistance, Multiple<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Humans<br/>Paclitaxel--metabolism<br/>Silymarin--pharmacology